Overview of Dr. Herr
Dr. Harry Herr is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. He received his medical degree from University of California, Irvine, School of Medicine and has been in practice 52 years. Dr. Herr accepts several types of health insurance, listed below. He is one of 76 doctors at Memorial Sloan Kettering Cancer Center and one of 189 doctors at New York-Presbyterian Hospital who specialize in Urology. He has more than 100 publications and over 500 citings.
Office
353 East 68th Street
New York, NY 10065
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1974 - 1976
- University of California (Irvine)Residency, Urology, 1971 - 1974
- Orange County Medical CenterResidency, Surgery, 1970 - 1971
- University of Southern California/LACUSC Medical CenterInternship, Transitional Year, 1969 - 1970
- University of California, Irvine, School of MedicineClass of 1969
Certifications & Licensure
- NY State Medical License 1973 - 2025
- CA State Medical License 1970 - 2023
- American Board of Urology Urology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas Start of enrollment: 2003 Oct 28
- Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- De-Escalation of Therapy for Low-Grade Papillary Bladder Tumors With Preserved Long-Term Oncologic Outcomes.Harry Herr
Urology Practice. 2024-09-01 - Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG).Roberto Contieri, Mark S Soloway, Paolo Gontero, Harry Herr, Wassim Kassouf
European Urology Oncology. 2024-08-31 - 2 citationsResponse to 2 Induction Courses of Bacillus Calmette-Guèrin Therapy Among Patients With High-Risk Non-Muscle-Invasive Bladder Cancer: 5-year Follow-Up of a Phase 2 Cli...Andrew B Katims, Jacob Tallman, Emily Vertosick, Shaun Porwal, Guido Dalbagni
JAMA Oncology. 2024-04-01
Journal Articles
- Importance of Wide Re‐Resection in Adult Spermatic Cord Sarcomas: Report on Oncologic Outcomes at a Single InstitutionMassimiliano Spaliviero, Kaled M Alektiar, Harry W Herr, Paul Russo, Journal of Surgical Oncology
Press Mentions
- Novel BCG Strategy for Bladder Cancer May Address Shortage of the DrugMarch 15th, 2024
Professional Memberships
- Member
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access Choice PPO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
Anthem Blue Preferred Plus POS
Anthem Blue Preferred Select
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOCoventry Florida - Employer Group PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: